GreenLight Biosciences Stock

greenlightbiosciences.comBioTechFounded: 2008Funding to Date: $141.55MM

GreenLight Biosciences is a biotech company leveraging RNA to tackle some of humanity's greatest challenges, including pandemics, rare diseases, biodiversity and climate change.

Register for Details

For more details on financing and valuation for GreenLight Biosciences, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Andrey Zarur Ph.D
Co-Founder, Chief Executive Officer, President & Board Member
Carole Cobb
Chief Operating Officer
Mick Messman
Chief Commercial Officer
Marta Ortega-Valle
Co-Founder & Senior Vice President, Corporate Development

Board Members

Andrey Zarur Ph.D
Charles Cooney Ph.D
Colin Steen
Syngenta Ventures
David Furneaux
Kodiak Venture Partners
David Russell Ph.D
Lewis & Clark Ventures
Eric O'Brien
Fall Line Capital
Ganesh Kishore Ph.D
Spruce Capital Partners
Gregory Lucier
James Swartz Ph.D
Jonathan Fleming
Oxford Bioscience Partners
Mark Cupta
Prelude Ventures
Martha Schlicher
Matthew Walker
Neil Renninger Ph.D
Khosla Ventures

Other companies like GreenLight Biosciences in the BioTech sector

Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$872.62MM
Sector
Last Round Est. Valuation
$486.63MM
Sector
Last Round Est. Valuation
$186.12MM
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$185MM

News

GreenLight Biosciences, a bio-performance company developing RNA-based solutions for agriculture and pharmaceutical applications, raised $50m in funding